Rina Delapena, NP
Nurse Practitioner · Banning
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Harbor Wound Care P C · Altea Medical California PC · California Wound and Hyperbaric Specialists Inc · Omar Osman Practice, LLC
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Rina Delapena’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- Illinois 209020998Advanced Practice Registered Nurse · since 2020 · expires 2022-08-31Not RenewedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$42,628
Medicare paid this office $42,628 for 170 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 58 | $17,517 | $59 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 78 | $11,743 | $83 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 64 | $6,845 | $104 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 51 | $3,767 | $56 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 13 | $1,656 | $118 |
See all 6 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 58 | $17,517 | $59 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 78 | $11,743 | $83 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 64 | $6,845 | $104 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 51 | $3,767 | $56 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 13 | $1,656 | $118 |
| Nursing facility discharge management, more than 30 minutes | 11 | $1,100 | $100 |
Who their Medicare patients are
170 Original Medicare patients in 2024. Average age 79 · Under 65 7% · 85 and older 34% · Women 54% · Also on Medicaid 62% · Health risk score 2.96. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 64% · Depression 51% · Coronary heart disease 44% · Heart failure 44% · Chronic kidney disease 43% · Dementia 43% · Atrial fibrillation 42% · COPD 31% · Stroke 27% · Cancer 19%.
The office billed $92,405, Medicare allowed $53,672 and paid $42,628; for 596 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 170 | 596 | 79 | 2.96 | $92,405 | $42,628 |
| 2023 | 260 | 1,922 | 77 | 4.21 | $357,232 | $143,263 |
| 2022 | 345 | 6,083 | 75 | 2.87 | $1,099,200 | $393,058 |
| 2021 | 215 | 1,305 | 75 | 2.12 | $237,610 | $87,739 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 247 | $86,712 | $80 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 186 | $25,514 | $54 |
| Advance care planning, first 30 minutes | 118 | $13,098 | $64 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 92 | $12,211 | $117 |
| Nursing facility discharge management, more than 30 minutes | 52 | $5,528 | $99 |
2022: 5 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 316 | $229,692 | $70 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 288 | $118,871 | $53 |
| Advance care planning, first 30 minutes | 175 | $20,663 | $66 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 134 | $16,031 | $102 |
| Nursing facility discharge management, more than 30 minutes | 90 | $7,553 | $79 |
2021: 5 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 183 | $46,050 | $72 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 142 | $25,399 | $54 |
| Advance care planning, first 30 minutes | 69 | $6,481 | $68 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 50 | $5,619 | $106 |
| Nursing facility discharge management, more than 30 minutes | 35 | $3,039 | $82 |
Medicaid work
$3,052 in 2024
Medicaid paid $3,052 for 166 billed services this clinician did in 2024, up to 38 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 108 | $2,042 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 58 | $1,010 |
| 2024 | 166 | 2 | 38 | $3,052 |
| 2023 | 2,073 | 5 | 80 | $17,716 |
| 2022 | 2,770 | 3 | 72 | $4,023 |
| 2021 | 352 | 2 | 38 | $0 |
See the largest Medicaid services in earlier years
2023
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 1,256 | $9,393 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 213 | $3,206 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 478 | $2,979 |
| SBSQ NURSING FACILITY CARE HIGH MDM 45 MINUTES | 112 | $1,998 |
| Nursing facility discharge management; more than 30 minutes total time on the date of the encounter | 14 | $140 |
2022
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 1,690 | $3,148 |
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 1,049 | $660 |
| Advance care planning including the explanation and discussion of advance directives such as standard forms (with completion of such forms, when performed), by the physician or other qualified health care professional; first 30 minutes, face-to-face with the patient, family member(s), and/or surrogate | 31 | $215 |
2021
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 149 | $0 |
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 203 | $0 |
Drugs they prescribed that Part D paid
$18,252
Pharmacies billed $18,252 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
657 generic and 51 brand-name prescriptions · $18,252 in drug cost · 103 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Enoxaparin | 16 | $3,134 | $196 |
| Risperidone | 98 | $2,460 | $25 |
| Gabapentin | 111 | $1,207 | $11 |
| Metformin | 158 | $1,194 | $8 |
| Pantoprazole | 58 | $929 | $16 |
See all 12 drugs
| Enoxaparin | 16 | $3,134 | $196 |
| Risperidone | 98 | $2,460 | $25 |
| Gabapentin | 111 | $1,207 | $11 |
| Metformin | 158 | $1,194 | $8 |
| Pantoprazole | 58 | $929 | $16 |
| Mirtazapine | 42 | $796 | $19 |
| Atorvastatin | 28 | $529 | $19 |
| Metoprolol | 22 | $229 | $10 |
| Sertraline | 14 | $191 | $14 |
| Levothyroxine | 24 | $137 | $6 |
| Buspirone | 24 | $126 | $5 |
| Lisinopril | 18 | $108 | $6 |
Year by year
| 2024 | 708 | 48 | None | 7% | $18,252 |
| 2023 | 1,093 | 164 | 5% (56) | 20% | $80,300 |
| 2022 | 1,667 | 172 | None | 27% | $115,068 |
| 2021 | 90 | 38 | 0% (0) | None | $3,436 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 27 drugs
| Trulicity | 17 | $8,431 | $496 |
| Levemir Flexpen | 12 | $7,060 | $588 |
| Novolog Flexpen | 11 | $6,138 | $558 |
| Risperidone | 47 | $1,422 | $30 |
| Autoshield Duo Pen Needle | 16 | $1,413 | $88 |
| Cephalexin | 16 | $1,050 | $66 |
| Dutasteride | 11 | $990 | $90 |
| Levothyroxine | 80 | $865 | $11 |
| Metformin | 76 | $791 | $10 |
| Sertraline | 17 | $721 | $42 |
| Gabapentin | 44 | $647 | $15 |
| Quetiapine | 24 | $623 | $26 |
| Mirtazapine | 17 | $583 | $34 |
| Atorvastatin | 31 | $448 | $14 |
| Olanzapine | 11 | $434 | $39 |
| Hydrocodone-Acetaminophen | 27 | $415 | $15 |
| Triamcinolone Acetonide | 18 | $413 | $23 |
| Furosemide | 25 | $286 | $11 |
| Amlodipine Besylate | 32 | $270 | $8 |
| Divalproex | 11 | $248 | $23 |
| Donepezil | 12 | $230 | $19 |
| Metoprolol | 11 | $155 | $14 |
| Benztropine Mesylate | 15 | $154 | $10 |
| Metoprolol | 14 | $143 | $10 |
| Glipizide | 14 | $117 | $8 |
| Pioglitazone | 12 | $111 | $9 |
| Carvedilol | 16 | $89 | $6 |
2022: 48 drugs
| Victoza 2-Pak | 23 | $12,504 | $544 |
| Lantus Solostar | 40 | $9,485 | $237 |
| Levemir Flextouch | 21 | $7,974 | $380 |
| Novolog Flexpen | 21 | $7,255 | $345 |
| Lantus | 22 | $6,730 | $306 |
| Trulicity | 14 | $6,640 | $474 |
| Basaglar Kwikpen U-100 | 26 | $2,668 | $103 |
| Autoshield Duo Pen Needle | 25 | $2,254 | $90 |
| Permethrin | 30 | $2,180 | $73 |
| Quetiapine | 41 | $1,701 | $41 |
| Levothyroxine | 168 | $1,615 | $10 |
| Mirtazapine | 36 | $1,276 | $35 |
| Metformin | 106 | $1,243 | $12 |
| Megestrol Acetate | 20 | $1,235 | $62 |
| Divalproex | 34 | $1,049 | $31 |
| Olanzapine Odt | 12 | $892 | $74 |
| Triamcinolone Acetonide | 42 | $878 | $21 |
| Diclofenac | 27 | $876 | $32 |
| Pantoprazole | 13 | $773 | $59 |
| Dutasteride | 13 | $720 | $55 |
| Olanzapine | 26 | $720 | $28 |
| Risperidone | 36 | $714 | $20 |
| Albuterol Sulfate Hfa | 12 | $706 | $59 |
| Bupropion | 15 | $665 | $44 |
| Cephalexin | 19 | $646 | $34 |
| Nitrofurantoin Mono-Macro | 31 | $561 | $18 |
| Amlodipine Besylate | 56 | $552 | $10 |
| Atorvastatin | 30 | $527 | $18 |
| Celecoxib | 13 | $527 | $41 |
| Isosorbide Dinitrate | 12 | $518 | $43 |
| Furosemide | 41 | $517 | $13 |
| Lisinopril | 36 | $468 | $13 |
| Escitalopram | 21 | $454 | $22 |
| Donepezil | 31 | $406 | $13 |
| Ondansetron Odt | 16 | $384 | $24 |
| Omeprazole | 16 | $330 | $21 |
| Fluoxetine | 16 | $306 | $19 |
| Gabapentin | 16 | $285 | $18 |
| Clindamycin | 13 | $277 | $21 |
| Potassium Chloride | 19 | $276 | $15 |
| Metoprolol | 19 | $266 | $14 |
| Glipizide | 21 | $233 | $11 |
| Levofloxacin | 13 | $218 | $17 |
| Trazodone | 13 | $179 | $14 |
| Sulfamethoxazole-Trimethoprim | 15 | $161 | $11 |
| Haloperidol | 14 | $143 | $10 |
| Benztropine Mesylate | 12 | $134 | $11 |
| Silver Sulfadiazine | 11 | $112 | $10 |
2021: 1 drug
| Triamcinolone Acetonide | 11 | $298 | $27 |
Money from drug and device companies
$271 in 2025
| 2025 | 2 | 2 | None | $271 |
| 2024 | 5 | 5 | None | $499 |
| 2023 | 4 | 5 | None | $581 |
| 2022 | 3 | 5 | None | $394 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $137 | 1 payment
|
| Neurelis | Valtoco | $134 | 1 payment
|
See all 2 published payments
| Edwards Lifesciences | Meals · 2025-03-28 | Sapien 3 Ultra Resilia | $137 |
| Neurelis | Meals · 2025-01-15 | Valtoco | $134 |
See earlier years (2024, 2023, 2022)
2024: $499
| Mayne Pharma Commercial | Annovera | $122 | 1 payment
|
| Averitas Pharma | Qutenza | $122 | 1 payment
|
| Sage Therapeutics | None | $107 | 1 payment
|
| Hologic Sales and Service | Aptima | $105 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo Xr | $44 | 1 payment
|
2023: $581
| Teva Pharmaceuticals USA | Austedo Xr | $241 | 2 payments
|
| Mayne Pharma Commercial | Nextstellis | $124 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Andexxa | $122 | 1 payment
|
| Biogen | None | $94 | 1 payment
|
2022: $394
| Neurocrine Biosciences | Ingrezza | $165 | 3 payments
|
| Smith+Nephew | Collagenase Santyl | $122 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $106 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 25.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1821623281
- Licence
- IL 209.020998Illinois 209020998: Not Renewed
- Trained
- Rush Medical College of Rush University, 2019
- Group
- Harbor Wound Care P C · Altea Medical California PC · California Wound and Hyperbaric Specialists Inc · Omar Osman Practice, LLC
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- Po Box 1060, Santa Clara, CA, 95052
- NPI first listed
- 2020-03-06
- NPI last updated
- 2021-06-09
- NPI record certified
- 2020-10-13
This is when the NPI record was last certified, not a medical board exam.